177 related articles for article (PubMed ID: 32085563)
1. Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma.
Nicolau-Neto P; de Souza-Santos PT; Severo Ramundo M; Valverde P; Martins I; Santos IC; Dias F; de Almeida Simão T; Ribeiro Pinto LF
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32085563
[TBL] [Abstract][Full Text] [Related]
2. ALCAM is a biomarker of tumor aggressiveness and worse prognosis in glottic laryngeal squamous cell carcinoma.
Nicolau-Neto P; Peryassú BC; de Carvalho FN; Souza-Santos PT; Valverde P; Nascimento CM; Costa I; Dias FL; Pinto LFR
Head Neck; 2024 Apr; 46(4):785-796. PubMed ID: 38196304
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
[TBL] [Abstract][Full Text] [Related]
4. Increased DSG2 plasmatic levels identified by transcriptomic-based secretome analysis is a potential prognostic biomarker in laryngeal carcinoma.
Cury SS; Lapa RML; de Mello JBH; Marchi FA; Domingues MAC; Pinto CAL; Carvalho RF; de Carvalho GB; Kowalski LP; Rogatto SR
Oral Oncol; 2020 Apr; 103():104592. PubMed ID: 32087405
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of Rab coupling protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Dai Y; Liu Y; Tian X; Zhang X
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):101-6. PubMed ID: 25975685
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of B7-H3 Is Associated With Poor Prognosis in Laryngeal Cancer.
Li Y; Cai Q; Shen X; Chen X; Guan Z
Front Oncol; 2021; 11():759528. PubMed ID: 34938657
[TBL] [Abstract][Full Text] [Related]
8. Identification of a seven-lncRNAs panel that serves as a prognosis predictor and contributes to the malignant progression of laryngeal squamous cell carcinoma.
Zheng X; Gao W; Zhang Z; Xue X; Mijiti M; Guo Q; Wusiman D; Wang K; Zeng X; Xue L; Guo Z; An C; Wu Y
Front Oncol; 2023; 13():1106249. PubMed ID: 37205188
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic analysis reveals prognostic value and immunotherapy potential of Siglec-15 in laryngeal squamous cell carcinoma.
Chen X; Cai Q; Wong K; Shen X; Guan Z
Heliyon; 2024 Feb; 10(3):e25266. PubMed ID: 38352733
[TBL] [Abstract][Full Text] [Related]
10. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic signature associated with RNA-binding proteins for survival stratification of laryngeal cancer.
Shen Y; Chen H; Huang Q; Du H; Zhou L
Aging (Albany NY); 2022 Aug; 14(16):6605-6625. PubMed ID: 35985767
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma.
Li H; Wang FL; Li W; Fei YH; Wang YT; Zhang JE; Bi HY; Zhang M
Am J Otolaryngol; 2019; 40(5):615-625. PubMed ID: 31128861
[TBL] [Abstract][Full Text] [Related]
13. SPINK5 is a Prognostic Biomarker Associated With the Progression and Prognosis of Laryngeal Squamous Cell Carcinoma Identified by Weighted Gene Co-Expression Network Analysis.
Liu J; Zhao J; Xu J; Sun Q; Qin X; Chen G; Gao T; Bai G; Guo Z
Evol Bioinform Online; 2022; 18():11769343221077118. PubMed ID: 35140453
[TBL] [Abstract][Full Text] [Related]
14. [Multivariate survival analysis in patient with laryngeal squamous cell carcinomas].
Guo J; Chen F; Guan Z; Chen Y; Li Q; Ouyang D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jul; 20(14):636-9. PubMed ID: 17017186
[TBL] [Abstract][Full Text] [Related]
15. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Fan L; Zhang A; Deng P
Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
[TBL] [Abstract][Full Text] [Related]
16. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI
Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007
[TBL] [Abstract][Full Text] [Related]
17. Integrative Analysis Reveals STC2 as a Prognostic Biomarker of Laryngeal Squamous Cell Carcinoma.
Zhong R; Zhan J; Zhang S
Appl Biochem Biotechnol; 2023 Oct; ():. PubMed ID: 37792175
[TBL] [Abstract][Full Text] [Related]
18. Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.
Li L; Wang J; Gao L; Gong L
Int J Clin Exp Pathol; 2015; 8(8):9232-9. PubMed ID: 26464671
[TBL] [Abstract][Full Text] [Related]
19. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
[TBL] [Abstract][Full Text] [Related]
20. Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
Karamagkiolas S; Giotakis I; Kyrodimos E; Giotakis EI; Kataki A; Karagianni F; Lazaris AM
Am J Otolaryngol; 2019; 40(4):487-493. PubMed ID: 30979652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]